CoChat

Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1

Open access
Patti, Mary-Elizabeth, Goldfine, Allison B. · 2014 · Gastroenterology
Cited by 68

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Obesity is increasingly recognized as a major threat to individual and public health. Unfortunately, it is very difficult to achieve sustained weight loss with current medical approaches. Similarly, optimal treatment of obesity-related comorbidities, including type 2 diabetes, hypertension, nonalcoholic fatty liver disease, and cardiovascular disease remains an elusive goal for the majority of patients. Given these critical unmet needs, both clinicians and patients alike have been buoyed by the results of recent, controlled, clinical trials demonstrating potent effects of bariatric operative procedures to induce sustained weight loss and improve or normalize obesity-related comorbidities, including type 2 diabetes.1–3 Perhaps even more compelling are the 83% reduction in incident diabetes, 30%–40% reduction in myocardial infarction and stroke, 42% reduction in cancer incidence in women, and 30%–40% reduction in overall mortality observed in nonrandomized but controlled studies.1, 4 As with any approach, clinicians need to carefully balance metabolic benefits against both short- and long-term complications of surgery. When surgery is performed at centers of excellence, these benefits are achieved with low operative mortality.1 However, longer term intestinal and nutritional complications can occur, and vary according to the specific procedure. One particularly challenging and sometimes severe complication of roux-en-Y gastric bypass surgery is postprandial hyperinsulinemic hypoglycemia.5, 6 Although it is likely that multiple mechanisms contribute to post-bypass hypoglycemia, the studies of Salehi et al7 reported in this issue of Gastroenterology provide firm evidence for the role of the incretin hormone glucagon-like peptide-1 (GLP-1) as a critical contributor to the inappropriate insulin secretion in this syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2014.01.038

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 68

Metadata

Authors
Patti, M.-E., & Goldfine, A. B.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2014-03
Volume
146
Issue
3
Pages
605-608
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1998723338
Cited by
68
References
18
FWCI
7.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1. https://app.cochat.ai/papers/10.1053/j.gastro.2014.01.038
The paper
Patti, M.-E., & Goldfine, A. B. (2014). Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1. Gastroenterology. https://doi.org/10.1053/j.gastro.2014.01.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.